Bacciu Andrea, Nusier Amjad, Lauda Lorenzo, Falcioni Maurizio, Russo Alessandra, Sanna Mario
Department of Clinical and Experimental Medicine, Otolaryngology Unit, University Hospital of Parma, Parma, Italy.
Audiol Neurootol. 2013;18(3):184-91. doi: 10.1159/000349990. Epub 2013 Apr 3.
To describe the decision-making strategies for complex facial nerve schwannomas (FNSs).
Charts belonging to 103 consecutive patients with facial nerve tumors managed between 1990 and 2011 were examined retrospectively to identify complex FNSs. To be classified as complex, at least one of the following criteria had to be met: (1) FNS with large intraparotid tumor component and preoperative good facial nerve function (3 cases); (2) multiple-segment FNSs with extension to both the cerebellopontine angle and the middle cranial fossa in patients with preoperative good hearing (5 cases); (3) fast-growing FNS with preoperative good facial nerve function (4 cases), and (4) large FNS compressing the temporal lobe with preoperative normal facial nerve function (1 case).
Thirteen patients were classified as complex; 12 patients had total tumor removal with sural nerve grafting and 1 patient had partial tumor removal. Two patients with intratemporal-intraparotid FNS underwent a transmastoid-transparotid approach. One patient with a tumor extending from the geniculate ganglion to the parotid portion of the facial nerve underwent a combined middle fossa transmastoid-transparotid approach. A transcochlear approach with temporal craniotomy was performed in all the patients with multiple-segment FNS as well as in patients with fast-growing tumors extending both in the cerebellopontine angle and middle cranial fossa. A partial tumor removal through the middle fossa approach was performed in 1 patient with a large tumor compressing the temporal lobe.
Therapeutic options for patients with FNS include surgical intervention, observation and radiotherapy. Nowadays, surgical resection with facial nerve repair is usually the standard management for patients with poor facial function (House-Brackmann grade III or worse). In patients presenting with normal or near-normal facial nerve function, initial observation with periodic examination and imaging is usually recommended. However, on rare occasions surgeons can be faced with a situation in which the management decision-making process is particularly challenging. In these complex cases treatment should be individualized. We recommend early surgical intervention regardless of the preoperative facial and hearing functions in the following cases: intratemporal FNSs extending with a large tumor component into the parotid, multiple-segment FNSs extending in both the cerebellopontine angle and the middle cranial fossa, fast-growing FNSs, and large FNSs with temporal lobe compression.
描述复杂面神经鞘瘤(FNS)的决策策略。
回顾性研究1990年至2011年间连续收治的103例面神经肿瘤患者的病历,以确定复杂FNS。若符合以下至少一项标准,则归类为复杂FNS:(1)腮腺内肿瘤成分大且术前面神经功能良好的FNS(3例);(2)术前听力良好、肿瘤累及桥小脑角和中颅窝的多节段FNS(5例);(3)术前面神经功能良好的快速生长型FNS(4例);(4)术前面神经功能正常、压迫颞叶的大型FNS(1例)。
13例患者被归类为复杂FNS;12例患者肿瘤全切并行腓肠神经移植,1例患者肿瘤部分切除。2例颞骨内-腮腺内FNS患者采用经乳突-腮腺入路。1例肿瘤从膝状神经节延伸至面神经腮腺段的患者采用中颅窝联合经乳突-腮腺入路。所有多节段FNS患者以及肿瘤快速生长且累及桥小脑角和中颅窝的患者均采用经颞骨岩部切开的经耳蜗入路。1例压迫颞叶的大型肿瘤患者采用中颅窝入路行肿瘤部分切除。
FNS患者的治疗选择包括手术干预、观察和放疗。如今,对面神经功能差(House-Brackmann分级III级或更差)的患者,手术切除并修复面神经通常是标准治疗方法。对于面神经功能正常或接近正常的患者,通常建议初始观察并定期进行检查和影像学检查。然而,在极少数情况下,外科医生可能会面临管理决策过程特别具有挑战性的情况。在这些复杂病例中,治疗应个体化。对于以下情况,无论术前面神经和听力功能如何,我们建议早期进行手术干预:颞骨内FNS伴有大的肿瘤成分延伸至腮腺、肿瘤累及桥小脑角和中颅窝的多节段FNS、快速生长型FNS以及压迫颞叶的大型FNS。